Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
Subscribe To Our Newsletter & Stay Updated